Sort
21,453 grants matching “tuberculosis”
TUBERCULOSIS ELIMINATION AND LABORATORY
$210,957Pat Frances Infield · Nebraska State Dept Of Health · U52 · FY2008 · PS
Host Pathogen Variation & TB Pathogenesis
$210,900Thomas R Hawn · University Of Washington · U19 · FY2025 · AI
Pyruvate Dehydrogenase E1: Structure-Function Studies
$210,870University Of Pittsburgh At Pittsburgh · R01 · FY2005 · GM
Pyruvate Dehydrogenase E1: Structure-Function Studies
$210,870University Of Pittsburgh At Pittsburgh · R01 · FY2004 · GM
Structure, Function, and Therapeutic Potential of Clostridium difficile Caseinolytic Protease P (Duerfeldt)
$210,830Adam Scott Duerfeldt · University Of Oklahoma · P20 · FY2017 · GM
Alcohol, SIV infection, and Host Defense
$210,750Steve Nelson · Lsu Health Sciences Center · P60 · FY2007 · AA
Transmission dynamics of Mycobacterium tuberculosis
$210,650Michael Shiloh · Ut Southwestern Medical Center · R21 · FY2018 · AI
Targeting type I interferon production in TB infection.
$210,625Amy K Barczak · Massachusetts General Hospital · R21 · FY2018 · AI
Host Proteomic Biosignatures for a Urine-based Diagnosis of Pulmonary Tuberculosis in Children
$210,600Devan Jaganath · University Of California, San Francisco · K23 · FY2021 · HL
IGF::OT::IGF Aerosolized Delivery of Anti-Tubercular Drugs
$210,507Darrick Carter · Pai Life Sciences, Inc. · N43 · FY2013 · AI
Tuberculosis case finding by oral swab PCR
$210,500Gerard A Cangelosi · University Of Washington · R21 · FY2015 · AI
Role of Pin-domain toxins in Mycobacterium tuberculosis pathogenesis
$210,489James Scott Butler · University Of Rochester · R21 · FY2010 · AI
Using PET isotopes to identify drug targets and to diagnose infectious diseases
$210,399Peter J Tonge · State University New York Stony Brook · R21 · FY2009 · AI
Host Proteomic Biosignatures for a Urine-based Diagnosis of Pulmonary Tuberculosis in Children
$210,394Devan Jaganath · University Of California, San Francisco · K23 · FY2022 · HL
Novel Reporter Phages to Detect Complex TB Drug Resistance and Persistence
$210,346Michelle H Larsen · Albert Einstein College Of Medicine · R01 · FY2015 · AI
Project 4: Biophysics of Mtb droplets and fluid spray technology to elucidate Mtb transmission
$210,215Lydia Bourouiba · Weill Medical Coll Of Cornell Univ · P01 · FY2023 · AI
Structure, Function, and Therapeutic Potential of Clostridium difficile Caseinolytic Protease P (Duerfeldt)
$210,167Adam Scott Duerfeldt · University Of Oklahoma · P20 · FY2020 · GM
Structure, Function, and Therapeutic Potential of Clostridium difficile Caseinolytic Protease P (Duerfeldt)
$210,167Adam Scott Duerfeldt · University Of Oklahoma · P20 · FY2019 · GM
Structure, Function, and Therapeutic Potential of Clostridium difficile Caseinolytic Protease P (Duerfeldt)
$210,167Adam Scott Duerfeldt · University Of Oklahoma · P20 · FY2018 · GM
Rapid screening for modes-of-action of M. tuberculosis inhibitors by high-throughput metabolic fingerprinting
$210,086Michael Berney · Albert Einstein College Of Medicine · R21 · FY2019 · AI
RIFAMYCIN BIOSYNTHETIC ANALOGS
$210,083Stanford University · R01 · FY2002 · AI
TB Diagnostics at the Point of Care
$210,060Christopher Gerard Cooney · Akonni Biosystems, Inc. · R43 · FY2011 · EB
Southwest Oncology Group
$210,028Lawrence E Flaherty · Wayne State University · U10 · FY2007 · CA
INHIBITORS OF MYCOBACTERIAL ARABINOSYLTRANSFERASES
$210,006Ohio State University · R01 · FY2001 · AI
MOLECULAR BIOLOGY OF UNIQUE WALL LIPIDS OF MYCOBACTERIA
$210,001Ohio State University · R01 · FY2000 · AI